JPH066564B2 - Optically active carboxylic acid ester compound - Google Patents
Optically active carboxylic acid ester compoundInfo
- Publication number
- JPH066564B2 JPH066564B2 JP25022789A JP25022789A JPH066564B2 JP H066564 B2 JPH066564 B2 JP H066564B2 JP 25022789 A JP25022789 A JP 25022789A JP 25022789 A JP25022789 A JP 25022789A JP H066564 B2 JPH066564 B2 JP H066564B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- optically active
- carboxylic acid
- acid ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明はアクチノボリンやバクトボリン等のδラクトン
系抗生物質の母核をなす式(9) で表わされる光学活性δラクトン化合物を製造する際の
中間体に関する。DETAILED DESCRIPTION OF THE INVENTION (Industrial field of application) The present invention relates to formula (9), which is the core of δ-lactone antibiotics such as actinovorin and bactoborin. The present invention relates to an intermediate for producing an optically active δ-lactone compound.
(従来の技術及び発明が解決しようとする課題) 上記式(9)で表わされるδラクトン化合物の製造に関
しては、ラセミ体についてはR.Cordova等(Tetrahedron
Lett.,25,2945(1984)),K.M.Pietrusiewicz等(J.Org.Ch
em.,53,2837(1988))が報告しているが光学活性体につ
いてはK.Mori等(Tetrahedron.,41,5295(1985))が知ら
れているのみである。(Prior Art and Problems to be Solved by the Invention) Regarding the production of the δ-lactone compound represented by the above formula (9), regarding the racemate, R. Cordova et al. (Tetrahedron
Lett., 25 , 2945 (1984)), KMPietrusiewicz et al. (J.Org.Ch
Em., 53 , 2837 (1988)), but K. Mori et al. (Tetrahedron. , 41, 5295 (1985)) are only known for optically active substances.
光学純度の高い該化合物を容易に収率よく得る方法は未
だ知られていない。A method for easily obtaining the compound having a high optical purity in a high yield has not yet been known.
(課題を解決するための手段) 本発明者は上記の点に鑑み、効率よく、ラセミ化を起す
ことなく簡単な反応経路で、収率よくδラクトン化合物
を得る目的で鋭意検討した結果、下記反応経路(II)に
従い、光学活性δラクトン化合物(6)から光学純度の
高い光学活性δラクトン化合物(9)が容易に得られる
ことを見出した。(Means for Solving the Problem) In view of the above points, the present inventor has made earnest studies for the purpose of efficiently obtaining a δ-lactone compound with a simple reaction route without causing racemization, and as a result, It was found that an optically active δ-lactone compound (9) with high optical purity can be easily obtained from the optically active δ-lactone compound (6) according to the reaction pathway (II).
反応経路(II) 本発明はこの反応経路(II)において得られる中間体を
提供するものである。Reaction pathway (II) The present invention provides the intermediate obtained in this reaction pathway (II).
すなわち、本発明は 一般式(B) (D−EはCH=CH又はCH2CH2を、R3は低級
アルキル基、アルケニル基又はベンジル基を、X′は水
素原子又はフェニルチオ基を、*は不斉炭素を表わ
す。) で表わされる光学活性カルボン酸エステル化合物(B)
を提供するものである。That is, the present invention has the general formula (B) (D-E is a CH = CH or CH 2 CH 2, R 3 is a lower alkyl group, an alkenyl group or a benzyl group, X 'is a hydrogen atom or a phenylthio group, * represents an asymmetric carbon.) Represented by Optically active carboxylic acid ester compound (B)
Is provided.
一般式(B)で表わされる化合物(B)のR3として
は、メチル、エチル、プロピル、イソプロピル、ブチ
ル、t−ブチル、ペンチル基等炭素数1〜5のアルキル
基、アリル、2−メチルアリル、2−ブテニル、3−ブ
テニル、2−ペンテニル基等炭素数3〜5のアルケニル
基又はベンジル基を挙げることができる。R 3 of the compound (B) represented by the general formula (B) is methyl, ethyl, propyl, isopropyl, butyl, t-butyl, pentyl group or another alkyl group having 1 to 5 carbon atoms, allyl, 2-methylallyl, Examples thereof include alkenyl groups having 3 to 5 carbon atoms such as 2-butenyl, 3-butenyl and 2-pentenyl groups, or benzyl groups.
本発明の化合物(B)は化合物(6)から化合物(7)
を経て合成され、化合物(6)は、反応経路(I)に従
って、グリシジルエーテル(2)から合成される。The compound (B) of the present invention includes compounds (6) to (7)
Compound (6) is synthesized from glycidyl ether (2) according to reaction pathway (I).
すなわち、光学活性なα,β不飽和δラクトン化合物
(6)は、既に本発明者らにより開示された方法(有機
合成化学協会誌45巻、1157頁(1987))によりグリシジル
エーテル(2)から、反応経路(I)に示すようにして
製造することができる。That is, the optically active α, β-unsaturated δ-lactone compound (6) can be prepared from the glycidyl ether (2) by the method already disclosed by the present inventors (Journal of Synthetic Organic Chemistry, Vol. 45, p. 1157 (1987)). Can be produced as shown in reaction pathway (I).
反応経路(I) 反応経路(I)においてR1は容易に脱離可能な保護基
を表わし、具体的にはベンジル、p−メトキシベンジ
ル、p−クロルベンジル基等のアラルキル基、メトキシ
メチル、t−ブトキシメチル、1−エトキシエチル、1
−イソプロポキシエチル基等のアルキルオキシアルキル
基、アリル、メタリル基等のアルケニル基又はテトラヒ
ドロフラニル、テトラヒドロピラニル基等の環内に異項
原子を含むシクロアルキル基を表わす。またR2はn−
ブチル、イソブチル、t−ブチル、メチルなどの低級ア
ルキル基を表わす。*は不斉炭素を表わす。Reaction pathway (I) In the reaction pathway (I), R 1 represents a protective group which can be easily eliminated, and specific examples thereof include aralkyl groups such as benzyl, p-methoxybenzyl and p-chlorobenzyl groups, methoxymethyl, t-butoxymethyl, 1 -Ethoxyethyl, 1
An alkyloxyalkyl group such as an isopropoxyethyl group, an alkenyl group such as an allyl group or a methallyl group, or a cycloalkyl group containing a hetero atom in the ring such as a tetrahydrofuranyl group or a tetrahydropyranyl group. R 2 is n-
It represents a lower alkyl group such as butyl, isobutyl, t-butyl and methyl. * Represents an asymmetric carbon.
前記反応経路(II)において、Xは水酸基、フェニルチ
オ基もしくは−OR1を、Yは水素原子若しくは−CO
2R3を表わす。X′とR1及びR3は上記と同一のも
のを表わす。In the reaction pathway (II), X is a hydroxyl group, a phenylthio group or -OR 1 , and Y is a hydrogen atom or -CO.
2 represents R 3 . X'and R 1 and R 3 represent the same as above.
以下詳細反応経路(IIa),(IIb)に従って、この化
合物(6)より出発して化合物(7)より本発明の化合
物(B)を構成する方法を詳細に説明する。A detailed description will be given below of a method of starting the compound (6) to form the compound (7) to form the compound (B) of the present invention according to the detailed reaction routes (IIa) and (IIb).
詳細反応経路(IIa) 詳細反応経路(IIb) a)δラクトン化合物Aの合成 光学活性α,β不飽和δラクトン化合物(6)に不活性
溶媒、例えばテトラヒドロフラン、エチレングリコール
ジメチルエーテル、トルエン、ジメチルホルムアミドな
どの溶媒中シアノ酢酸エステル(式CH2(CN)CO
2R3中のR3は前記と同一のものを表わす。)のアニ
オンを1,4−付加させて化合物(A−1)(X=O
R1,Y=CO2R3)を合成し、これら工程1)エス
テルの加水分解と脱炭酸、工程2)保護基の脱離、工程
3)生じた水酸基のフェニルチオ基への変換を行ない、
化合物(A−4)(X=SC6H5,Y=H)を合成す
る。Detailed reaction pathway (IIa) Detailed reaction pathway (IIb) a) Synthesis of δ-lactone compound A An optically active α, β-unsaturated δ-lactone compound (6) in an inert solvent such as tetrahydrofuran, ethylene glycol dimethyl ether, toluene, dimethylformamide or the like cyanoacetic acid ester (formula CH 2 (CN ) CO
R 3 in 2 R 3 represents a the same as above. 1,4-addition of the anion of compound (A-1) (X = O
R 1 , Y = CO 2 R 3 ) is synthesized, and these steps 1) hydrolysis and decarboxylation of the ester, step 2) elimination of the protecting group, step 3) conversion of the resulting hydroxyl group to a phenylthio group are carried out,
Compound (A-4) (X = SC 6 H 5, Y = H) is synthesized.
1)エステルの加水分解と脱炭酸、2)保護基の脱離、
3)生じた水酸基のフェニルチオ基への変換の工程の順
序は1)→2)→3)でも2)→1)→3)でも、2)
→3)→1)でも良い。1) hydrolysis and decarboxylation of ester, 2) elimination of protecting group,
3) The order of the steps of converting the generated hydroxyl group to a phenylthio group is 1) → 2) → 3) or 2) → 1) → 3) or 2).
→ 3) → 1) is also acceptable.
1),2),3)の工程は各々それ自体公知の方法によ
って行うことができる。Each of steps 1), 2) and 3) can be performed by a method known per se.
工程1)はアルカリあるいは酸触媒を用い、含水溶媒中
で加熱環流して行う。アルカリとしては炭酸ナトリウ
ム、炭酸カリウム、水酸化ナトリウム、水酸化カリウム
などを用いることができる。酸としては硫酸、塩酸、臭
化水素酸、リン酸などの鉱酸あるいは塩化マグネシウ
ム、塩化亜鉛、硫酸銅などのルイス酸を用いることがで
きる。溶媒としては極性溶媒、例えばメタノール、エタ
ノール、イソプロピルアルコール、アセトニトリル、ア
セトン、ジメチルホルムアミド、ジメチルアセトアミド
などが使用できる。The step 1) is carried out by heating under reflux in a water-containing solvent using an alkali or acid catalyst. As the alkali, sodium carbonate, potassium carbonate, sodium hydroxide, potassium hydroxide or the like can be used. As the acid, a mineral acid such as sulfuric acid, hydrochloric acid, hydrobromic acid or phosphoric acid or a Lewis acid such as magnesium chloride, zinc chloride or copper sulfate can be used. As the solvent, polar solvents such as methanol, ethanol, isopropyl alcohol, acetonitrile, acetone, dimethylformamide and dimethylacetamide can be used.
工程2)の保護基の脱離は選択させるR1により適宜種
々の方法を使いわけることができる。例えばR1がベン
ジル、アリル基のときはパラジウム触媒を用いて水素化
分解あるいは異性化分解の手法が、メトキシメチルや1
−エトキシエチルの場合は鉱酸や有機酸、ルイス酸を用
いて含水溶媒中で加水分解する手法が使用できる。水酸
基をフェニルチオ基に変換する工程3)はトリフェニル
ホスフィン、トリ−n−ブチルホスフィン、1,2−ビス
(ジフェニルホスフォ)エタンなどの三級ホスフィンの
存在下ジフェニルスルフィドと原料のアルコールをピリ
ジン、トリエチルアミンなどを溶媒として反応させるこ
とにより達成できる。Various methods can be appropriately used for the removal of the protecting group in step 2) depending on the selected R 1 . For example, when R 1 is a benzyl or allyl group, the method of hydrogenolysis or isomerization using a palladium catalyst is methoxymethyl or 1
In the case of ethoxyethyl, a method of hydrolyzing in a water-containing solvent using a mineral acid, an organic acid or a Lewis acid can be used. In the step 3) of converting a hydroxyl group into a phenylthio group, diphenyl sulfide and the raw material alcohol are converted to pyridine in the presence of a tertiary phosphine such as triphenylphosphine, tri-n-butylphosphine and 1,2-bis (diphenylphospho) ethane. This can be achieved by reacting with triethylamine or the like as a solvent.
また化合物(A−1)(X=OR1,Y=CO2R3)
を工程2)→3)→1)の経路で反応させると化合物
(A−5)(X=OH,Y=CO2R3)、(A−6)
(X=SC6H5,Y=CO2R3)を経て化合物(A
−4)(X=SC6H5,Y=H)に導くこともでき
る。Further, the compound (A-1) (X = OR 1 , Y = CO 2 R 3 )
Is reacted in the route of steps 2) → 3) → 1) to give compound (A-5) (X = OH, Y = CO 2 R 3 ), (A-6).
(X = SC 6 H 5 , Y = CO 2 R 3 ) and then the compound (A
-4) (X = SC 6 H 5 , Y = H) can also be obtained.
化合物(A−1)(X=OR1,Y=CO2R3)から
化合物(A−4)(X=SC6H5,Y=H)への変換
の具体例を以下に示すが、製法はこの具体例に限られる
ものではない。Specific examples of conversion of the compound (A-1) (X = OR 1 , Y = CO 2 R 3 ) to the compound (A-4) (X = SC 6 H 5 , Y = H) are shown below, The manufacturing method is not limited to this specific example.
化合物(A−1)(X=OBn,Bnはベンジル基を示
す。Y=CO2C2H5)を塩化マグネシウムとジメチ
ルアセトアミド中で加熱し、加水分解・脱炭酸し、シリ
カゲルカラムクロマトグラフィーで分離、精製し、化合
物(A−2)(X=OBn,Y=H)のトランス体、シ
ス体を各々得ることができる。このものをパラジウム触
媒を用い、水素化分解し、化合物(A−3)(X=O
H,Y=H)とし、トリ−n−ブチルホスフィン、ジフ
ェニルスルフィドとピリジン中で反応させて化合物(A
−4)(X=SC6H5,Y=H)を得る。Compound (A-1) (X = OBn, Bn represents a benzyl group. Y = CO 2 C 2 H 5 ) is heated in magnesium chloride and dimethylacetamide, hydrolyzed and decarboxylated, and subjected to silica gel column chromatography. By separating and purifying, a trans isomer and a cis isomer of compound (A-2) (X = OBn, Y = H) can be obtained. This was hydrolyzed with a palladium catalyst to give compound (A-3) (X = O
H, Y = H), and reacted with tri-n-butylphosphine and diphenyl sulfide in pyridine to give compound (A
-4) (X = SC 6 H 5 , Y = H) is obtained.
b)ヘミアセタール化合物(7)の合成 化合物(A−4)(X=SC6H5,Y=H)をジイソ
ブチルアルミニウムハイドライドなどの水素化アルミニ
ウム試剤で還元するとヘミアセタール(7−1)が得ら
れる。反応はテトラヒドロフラン、エチレングリコール
ジメチルエーテル、ジオキサンなどの不活性溶媒中、0
〜−80°の低温で行う。化合物(7−2)(X′=H)
は化合物(7−1)(X′=−SC6H5)をラネーニ
ッケルを用いて還元することにより得られる。b) hemiacetal compound solution of compound (7) (A-4) (X = SC 6 H 5, Y = H) a reduction to the hemiacetal aluminum hydride reagent such as diisobutyl aluminum hydride (7-1) is obtained To be The reaction is carried out in an inert solvent such as tetrahydrofuran, ethylene glycol dimethyl ether, dioxane, etc.
Perform at a low temperature of ~ -80 °. Compound (7-2) (X '= H)
The compound (7-1) (X '= - SC 6 H 5) obtained by the reduction using Raney nickel.
c)カルボン酸エステル化合物Bの合成 化合物(7−1)を一般式R3OCOCH=PZR
4(8)で表わされるp−イリド(式(8)でZは酸
素、(OR3)2または(C6H5)2を、R4はOR
3またはC6H5を、R3は前記と同一のものを表わ
す。)と反応させて化合物(B−1)(D−E;CH=
CH,X′=SC6H5)を得る。化合物(B−1)か
ら化合物(C−2)(X′=H)へは工程4)二重結合
の還元、工程5)フェニルチオ基の還元、工程6)ニト
リルの加水分解、工程7)δラクトン環への閉環の4つ
の工程を行うことにより達成できる。尚、化合物(7−
2)(X′=H)を原料とした場合は工程5)は必要な
い。c) Synthesis of Carboxylic Acid Ester Compound B Compound (7-1) can be prepared by using the general formula R 3 OCOCH = PZR.
4 p-ylide represented by (8) (in the formula (8), Z is oxygen, (OR 3 ) 2 or (C 6 H 5 ) 2 and R 4 is OR.
3 or C 6 H 5 and R 3 is the same as defined above. ) To react with compound (B-1) (DE; CH =
CH, X '= SC 6 H 5) obtained. From compound (B-1) to compound (C-2) (X ′ = H), step 4) reduction of double bond, step 5) reduction of phenylthio group, step 6) hydrolysis of nitrile, step 7) δ This can be achieved by carrying out the four steps of ring closure to the lactone ring. The compound (7-
2) Step 5) is not necessary when (X '= H) is used as the raw material.
この4つの工程は工程7)のまえに工程6)を行う事を
除き、各々独立しており、どの順序で行ってもよい。ま
た4),5)の工程、6),7)の工程を同時に行うこ
ともできる。各々の工程はそれ自体公知の方法により行
うことができる。すなわち、工程4)二重結合の還元は
亜鉛−酢酸あるいはパラジウム、白金、ラネーニッケル
等による接触水素化により行うことができ、工程5)の
フェニルチオ基の還元はラネーニッケルによる接触還元
で達成できる。工程6)のニトリルの加水分解は塩酸、
硫酸、臭化水素酸などの鉱酸を用いるか水酸化ナトリウ
ム、水酸化カリウムなどの塩基を用いて含水溶媒中で加
熱すれば達成できる。また工程7)のδラクトン環への
閉環はニトリルの加水分解で生じたカルボン酸を酸処理
すれば達成できる。これらの各工程を適宜選択すれば望
ましい生成物を選択的に得ることができる。These four steps are independent of each other except that step 6) is performed before step 7), and they may be performed in any order. Also, the steps 4) and 5) and the steps 6) and 7) can be performed simultaneously. Each step can be performed by a method known per se. That is, the reduction of the double bond in step 4) can be carried out by catalytic hydrogenation with zinc-acetic acid or palladium, platinum, Raney nickel, etc., and the reduction of the phenylthio group in step 5) can be achieved by catalytic reduction with Raney nickel. Hydrolysis of the nitrile in step 6) is performed with hydrochloric acid,
This can be achieved by using a mineral acid such as sulfuric acid or hydrobromic acid or heating with a base such as sodium hydroxide or potassium hydroxide in a water-containing solvent. Further, the ring closure to the δ-lactone ring in step 7) can be achieved by treating the carboxylic acid generated by the hydrolysis of nitrile with an acid. A desired product can be selectively obtained by appropriately selecting each of these steps.
例えば化合物(B−1)(D−E;CH=CH、X′=
SC6H5)を亜鉛−酢酸で還元すると化合物(B−
2)(D−E;CH2CH2,X′=SC6H5)が得
られ、化合物(B−1)(D−E;CH=CH,X′=
SC6H5)をラネーニッケルで還元するとフェニルチ
オ基の還元と二重結合の還元が同時におこり、化合物
(B−3)(D−E;CH2CH2,X′=H)が得ら
れる。For example, compound (B-1) (DE; CH = CH, X '=
SC 6 H 5 ) is reduced with zinc-acetic acid to give compound (B-
2) (D-E; CH 2 CH 2, X '= SC 6 H 5) are obtained, the compound (B-1) (D- E; CH = CH, X' =
SC 6 H 5) a occur reduction of reducing the double bond of the phenylthio group reduced with Raney nickel at the same time, the compound (B-3) (D- E; CH 2 CH 2, X '= H) are obtained.
本発明の化合物Bは前記反応経路(II)に従って、光学
活性δラクトン化合物(9)とすることができる。以下
順に説明する。The compound B of the present invention can be converted into the optically active δ-lactone compound (9) according to the above reaction pathway (II). The following will be described in order.
d)δラクトン化合物Cの合成 上記化合物(B−3)のニトリル基を水酸化ナトリウム
存在下、エタノール中加熱還流して加水分解し、生じた
カルボン酸を塩酸で処理してδラクトン化合物(C−
2)(X′=H,R3=H)とし、低級アルコールと酸
触媒存在下で反応させるか、ジアゾメタンと反応させエ
ステル化して化合物(C−2)(X′=H)とする。工
程5)のフェニルチオ基の還元は化合物(B)から
(C)への変換の際行う代りに化合物(C)から(9)
への変換の際に行っても良い。この場合は化合物(B)
から(C)への工程4)を亜鉛−酢酸もしくはパラジウ
ムや白金による水素化で行い、工程6),7)を前述の
方法で行って化合物(C−1)(X′=SC6H5)を
得、これをラネーニッケルで水素化し、化合物(C−
2)(X′=H)としたのち最後の分子内縮環反応を行
う。d) Synthesis of δ-lactone compound C The nitrile group of the above compound (B-3) is heated under reflux in ethanol in the presence of sodium hydroxide to hydrolyze, and the resulting carboxylic acid is treated with hydrochloric acid to prepare the δ-lactone compound (C −
2) (X '= H, R 3 = H) and then, is reacted with a lower alcohol and an acid catalyst presence, compound esterified is reacted with diazomethane (C-2) (X' and = H). The reduction of the phenylthio group in step 5) is performed from the compound (C) to (9) instead of converting the compound (B) to (C).
It may be done at the time of conversion to. In this case, compound (B)
Step (4) to (C) is carried out by hydrogenation with zinc-acetic acid or palladium or platinum, and steps (6) and 7) are carried out by the method described above to give compound (C-1) (X ′ = SC 6 H 5 ) Was obtained and hydrogenated with Raney nickel to give the compound (C-
2) After setting (X '= H), the final intramolecular condensation reaction is carried out.
ここで得られたδラクトン化合物(A)、ヘミアセター
ル化合物(7)、カルボン酸エステル化合物(B)及び
δラクトン化合物(C)はいずれも文献未記載の新規化
合物であり、次に述べる光学純度の高いδラクトン化合
物(9)を製造する上で重要な中間体である。The δ-lactone compound (A), the hemiacetal compound (7), the carboxylic acid ester compound (B) and the δ-lactone compound (C) obtained here are all novel compounds not described in the literature, and the optical purity described below. It is an important intermediate for producing a high δ lactone compound (9).
e)δラクトン化合物(9)の合成 化合物(C−2)(X′=H)の分子内縮環反応は不活
性溶媒、例えばテトラヒドロフランやエチレングリコー
ルジメチルエーテル、t−ブタノール、ジメチルホルム
アミドなどを用い、カリウム−t−ブトキシド、水素化
ナトリウム、水酸化ナトリウム、水酸化カリウムなどの
塩基と反応させて公知の目的物質、光学活性δラクトン
化合物(9)を光学純度よく高収率で得る事ができる。e) Synthesis of δ-lactone compound (9) The intramolecular condensation reaction of the compound (C-2) (X ′ = H) uses an inert solvent such as tetrahydrofuran, ethylene glycol dimethyl ether, t-butanol or dimethylformamide. By reacting with a base such as potassium t-butoxide, sodium hydride, sodium hydroxide or potassium hydroxide, the known target substance, the optically active δ-lactone compound (9), can be obtained with high optical purity and high yield.
(発明の効果) 本発明の光学活性化合物はδラクトン系抗生物質の母核
をなす化合物を製造する際の中間体として重要な化合物
であって、この化合物を用いることにより光学純度の高
いδラクトン化合物(9)を効率よく製造することがで
きる。(Effect of the invention) The optically active compound of the present invention is an important compound as an intermediate in the production of a compound forming the nucleus of a δ-lactone antibiotic, and by using this compound, a δ-lactone having a high optical purity is obtained. The compound (9) can be efficiently produced.
(実施例) 以下具体例を実施例にもとづき、述べる。(Example) A specific example will be described below based on an example.
実施例1 1)化合物(A−1)の合成 (Bnはベンジル基、Etはエチル基を表わす。以下同
じ。) アルゴン気流下、シアノ酢酸エチルエステル1.24g(11m
M)を鉱油でけんだくした60W/W%の水素化ナトリウム
440mg(11mM)のテトラヒドロフラン15mlけんだく液中に
氷冷下で加え10分間室温で撹拌した。次にS体のα,β
不飽和δラクトン(6)2.0g(9.17mM)のテトラヒドロフ
ラン溶液5mlを氷冷下ゆっくり加え、同温で1時間撹拌
した。反応液をジエチルエーテル50mlで希釈し、10%塩
酸を加え中和し、分液し、有機層を飽和食塩水で洗浄
し、無水硫酸マグネシウムで乾燥後、減圧下溶媒を留去
すると1,4−付加体(A−1)が黄色油状物質として3.5
g得られた。1 HNMR(CDCl3) δ:1.32(3H,t,J=7.1Hz) 2.0 (2H,m) 2.60(2H,m) 2.90(1H,m) 3.60(3H,m) 4.30(2H,q,J=7.1Hz) 4.56(2H,s) 4.60(1H,m) 7.33(5H,s) IR(neat) 2940,2250,1740,740,700cm-1 MS m/e 332(M+1)、91(100%) 2)化合物(A−2)の合成 アルゴン気流下、上記1,4−付加体(A−1)3.5gを水1
0滴、塩化マグネシウム6水塩1.86g(9.17mM)とジメチル
アセトアミド30ml中で170℃、12時間加熱還流し、室温
にもどしたのち、水とジエチルエーテルを加え、抽出分
離し、水層は塩酸で酸性にしたのち酢酸エチルで抽出し
た。有機層をあわせて無水硫酸マグネシウムで乾燥し、
減圧下溶媒を留去し、残渣をベンゼン50mlにとかし、12
時間加熱還流した。次に反応液を減圧下溶媒を留去し、
残渣をシリカゲルカラムクロマトグラフィーに付し、エ
ーテル:ヘキサン(100:1v/v)流出し、3R,5Sのδ
ラクトン化合物(A−2)を無色油状物質として1.47g
((6)より62%)得た。更にエーテルで溶出して3S,5
Sのδラクトン化合物(A−2)185mg((6)より7.8
%)を得た。3R,5Sのδラクトン化合物(A−2)のデ
ータは次の通りである。1 HNMR(CDCl3) δ:1.7 〜2.9(7H,m) 3.65 (2H,d,J=4.4Hz) 4.58 (2H,s) 4.6 (1H,m) 7.33 (5H,s) IR(neat) 2940,2250,1740,742,700cm-1 MS m/e 259(M+)、91(100%) 3)化合物(A−3)の合成 上記3R,5S体のδラクトン化合物(A−2)1.38g(5.33m
M)を酢酸エチル40mlにとかし、水酸化パラジウム180m
g、濃塩酸1滴を加え水素ガス雰囲気下室温で3時間撹
拌した。反応液をセライトろ過し、減圧下溶媒を留去
し、残渣をシリカゲルカラムクロマトグラフィーに付
し、酢酸エチル留分より化合物(A−3)を無色油状物
質として866.7mg得た。収率96%1 HNMR(CDCl3) δ:1.65〜3.1(8H,m) 3.78 (2H,m) 4.57 (1H,sextet,J=4.4Hz) IR(neat) 3330,2250,1735cm-1 MS m/e 170(M+1)、138(100%) 4)化合物(A−4)の合成 (phはフェニル基を、Buはブチル基を表わす。以下
同じ。) アルゴン気流下、上記化合物(A−3)50mg(0.296m
M)、ジフェニルジスルフィド193mg(0.888mM)、トリ−n
−ブチルフォスフィン0.22ml(0.888mM)をピリジン2mlに
加え、室温で12時間撹拌する。反応液を酢酸エチル30ml
で希釈し、10%塩酸で洗浄し、次いで飽和硫酸銅水溶
液、飽和重曹水、飽和食塩水の順に洗浄し、無水硫酸マ
グネシウムで乾燥し、減圧下溶媒留去し、残渣をシリカ
ゲルカラムクロマトグラフィーに付し、エーテル留分よ
り、フェニルスルフィド(A−4)71mg(92%)を得
た。1 HNMR(CDCl3) δ:1.85〜2.75(7H,m) 2.94 (1H,dd,J=14.5,9.0Hz) 3.30 (1H,dd,J=14.5,5.8Hz) 4.45 (1H,tt,J= 9.0,5.8Hz) 7.30 (5H,m) IR(neat) 2930,2250,1740,740,695cm-1 MS m/e 261(M+)、123(100%) 5)化合物(7−1)の合成 アルゴン気流下、上記フェニルスルフィド(A−4)98
4mg(3.77mM)のテトラヒドロフラン溶液25mlに−30℃撹
拌下ジイソブチルアルミニウムハイドライドの2Mトル
エン溶液2ml(4mM)をゆっくり加え、−30℃で10分間撹拌
した。反応液に10%NaOH水溶液を少量加え、室温で
2時間撹拌し、セライトろ過した後、減圧下溶媒を留去
し、ヘミアセタール(7−1)986mgを得た。1 HNMR(CDCl3) δ:1.5〜1.9(4H,m) 2.2〜2.5(2H,m) 2.7 (1H,m) 2.9〜3.6(2H,m) 3.7〜4.4(1H,m) 5.0〜5.4(1H,m) 7.2〜7.45(2H,m) IR(neat) 3400,2910,2250,745,695cm-1 MS m/e 263(M+)、124(100%) 6)化合物(B−1)の合成 アルゴン気流下、上記ヘミアセタール(7−1)986mg
(3.75mM)の塩化メチレン溶液20mlにトリフェニルフォス
フィンのエトキシカルボニルメチルイリド3.9g(11.25m
M)を加え、室温で15時間撹拌する。反応液を減圧下溶媒
留去し、残渣をシリカゲルカラムクロマトグラフィーに
付し、エーテル:ヘキサン(3:1v/v)留分より5
−シアノメチル−7−ヒドロキシ−8−フェニルチオオ
クタ−2−エノイックアシッドエチルエステル(B−
1)を1.03g(82%)無色油状物質として得た。1 HNMR(CDCl3) δ:1.29 (3H,t,J=7.1Hz) 1.60 (2H,m) 2.0 〜2.7(5H,m) 2.68 (1H,dd,J=13.9,8.8Hz) 3.15 (1H,dd,J=13.9,3.7Hz) 3.70 (1H,m) 4.90 (2H,q,J= 7.1Hz) 5.90 (1H,d,J=15.6Hz) 6.80 (1H,dt,J=15.6,7.1Hz) IR(neat) 3450,2910,2250,1910,1650,740,690cm-1 MS m/e 333(M+)、124(100%) 7)化合物(B−3)の合成 上記化合物(B−1)87mg(0.26mM)のエタノール1ml溶
液にラネーニッケル0.6mMのエタノール溶液0.6mlを加
え、90℃で20分加熱還流した後、反応液をセライトろ過
し、減圧下溶媒を留去し、残渣をシリカゲルカラムクロ
マトグラフィーに付し、エーテル:ヘキサン(7:1v
/v)留分より化合物(B−3)37.2mg(63%)を無色
油状物質として得た。1 HNMR(CDCl3) δ:1.23 (3H,t,J=6.3Hz) 1.26 (3H,t,J=7.1Hz) 1.4 〜1.8(7H,m) 1.95 (1H,m) 2.33 (2H,t,J=6.6Hz) 2.48 (2H,d,J=5.4Hz) 3.90 (1H,m) 4.14 (2H,g,J=7.1Hz) IR(neat) 3400,2250,1725cm-1 MS m/e 228(M+1)、164(100%) 合成例 化合物(C−2)の合成 アルゴン気流下、上記化合物(B−3)250mg(1.1mM)を
30%水酸化カリウム水溶液1ml、エタノール8mlにとか
し、12時間加熱還流した。反応液にエーテル30ml、水20
mlを加え、抽出分離し、水層に濃塩酸を加え酸性とし、
塩化メチレンで抽出した。有機層をあわせて無水硫酸マ
グネシウムで乾燥し、減圧下溶媒を留去した。残渣を塩
化メチレンでとかし、ジアゾメタンのエーテル溶液を加
えてメチルエステルとした。これを減圧下溶媒留去し、
残渣をシリカゲルカラムクロマトグラフィーに付し、エ
ーテル:ヘキサン(1:1v/v)留分より(C−2)
192.1mg(82%)を無色結晶として得た。Example 1 1) Synthesis of compound (A-1) (Bn represents a benzyl group and Et represents an ethyl group. The same applies hereinafter.) 1.24 g (11 m of ethyl cyanoacetate under an argon stream.
60% w / w% sodium hydride prepared by adding M) to mineral oil
440 mg (11 mM) of tetrahydrofuran in 15 ml of suspension was added under ice-cooling and stirred for 10 minutes at room temperature. Next, α and β of S body
5 ml of a tetrahydrofuran solution containing 2.0 g (9.17 mM) of unsaturated δ-lactone (6) was slowly added under ice cooling, and the mixture was stirred at the same temperature for 1 hour. The reaction mixture was diluted with 50 ml of diethyl ether, neutralized with 10% hydrochloric acid, separated, the organic layer was washed with saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure to give 1,4 -The adduct (A-1) is 3.5 as a yellow oil.
g got. 1 HNMR (CDCl 3 ) δ: 1.32 (3H, t, J = 7.1Hz) 2.0 (2H, m) 2.60 (2H, m) 2.90 (1H, m) 3.60 (3H, m) 4.30 (2H, q, J = 7.1Hz) 4.56 (2H, s) 4.60 (1H, m) 7.33 (5H, s) IR (neat) 2940,2250,1740,740,700cm -1 MS m / e 332 (M + 1), 91 (100%) 2) Synthesis of compound (A-2) Under an argon stream, 3.5 g of the 1,4-addition product (A-1) was added to 1 part of water.
0 drops, 1.86 g (9.17 mM) of magnesium chloride hexahydrate and 30 ml of dimethylacetamide were heated to reflux for 12 hours at 170 ° C, and after returning to room temperature, water and diethyl ether were added, and extraction separation was carried out. It was acidified with and extracted with ethyl acetate. The organic layers are combined and dried over anhydrous magnesium sulfate,
The solvent was distilled off under reduced pressure, and the residue was dissolved in 50 ml of benzene.
Heated to reflux for hours. Next, the reaction solution is evaporated under reduced pressure to remove the solvent,
The residue was subjected to silica gel column chromatography, ether: hexane (100: 1 v / v) was flown out, and δ of 3R, 5S was calculated.
1.47 g of a lactone compound (A-2) as a colorless oily substance
(62% from (6)). Further elute with ether to give 3S, 5
Δ lactone compound of S (A-2) 185 mg (7.8 from (6)
%) Was obtained. The data of the 3R, 5S delta lactone compound (A-2) are as follows. 1 HNMR (CDCl 3 ) δ: 1.7 to 2.9 (7H, m) 3.65 (2H, d, J = 4.4Hz) 4.58 (2H, s) 4.6 (1H, m) 7.33 (5H, s) IR (neat) 2940 , 2250,1740,742,700 cm -1 MS m / e 259 (M +), 91 (100%) 3) Synthesis of compound (A-3) 1.38 g (5.33 m) of 3R, 5S delta lactone compound (A-2)
(M) in ethyl acetate (40 ml) and palladium hydroxide (180 m)
g and 1 drop of concentrated hydrochloric acid were added, and the mixture was stirred under a hydrogen gas atmosphere at room temperature for 3 hours. The reaction solution was filtered through Celite, the solvent was evaporated under reduced pressure, and the residue was subjected to silica gel column chromatography to obtain 866.7 mg of the compound (A-3) as a colorless oily substance from the ethyl acetate fraction. Yield 96% 1 HNMR (CDCl 3 ) δ: 1.65 to 3.1 (8H, m) 3.78 (2H, m) 4.57 (1H, sextet, J = 4.4Hz) IR (neat) 3330,2250,1735cm -1 MS m / E 170 (M + 1), 138 (100%) 4) Synthesis of compound (A-4) (Ph represents a phenyl group and Bu represents a butyl group. The same shall apply hereinafter.) 50 mg (0.296 m) of the above compound (A-3) under an argon stream.
M), diphenyl disulfide 193 mg (0.888 mM), tri-n
-Butylphosphine 0.22 ml (0.888 mM) is added to pyridine 2 ml and stirred at room temperature for 12 hours. 30 ml of ethyl acetate in the reaction solution
Dilute with, wash with 10% hydrochloric acid, then with saturated aqueous copper sulfate solution, saturated aqueous sodium hydrogen carbonate, and saturated brine in that order, dry over anhydrous magnesium sulfate, evaporate the solvent under reduced pressure, and apply the residue to silica gel column chromatography. Then, 71 mg (92%) of phenyl sulfide (A-4) was obtained from the ether fraction. 1 HNMR (CDCl 3 ) δ: 1.85 to 2.75 (7H, m) 2.94 (1H, dd, J = 14.5,9.0Hz) 3.30 (1H, dd, J = 14.5,5.8Hz) 4.45 (1H, tt, J =) 9.0,5.8Hz) 7.30 (5H, m) IR (neat) 2930,2250,1740,740,695cm -1 MS m / e 261 (M + ), 123 (100%) 5) Synthesis of compound (7-1) Phenyl sulfide (A-4) 98 under argon flow
To 25 ml of a tetrahydrofuran solution containing 4 mg (3.77 mM), 2 ml (4 mM) of a 2M toluene solution of diisobutylaluminum hydride was slowly added with stirring at -30 ° C, and the mixture was stirred at -30 ° C for 10 minutes. A small amount of 10% NaOH aqueous solution was added to the reaction solution, the mixture was stirred at room temperature for 2 hours, filtered through Celite, and the solvent was distilled off under reduced pressure to obtain 986 mg of hemiacetal (7-1). 1 HNMR (CDCl 3 ) δ: 1.5 to 1.9 (4H, m) 2.2 to 2.5 (2H, m) 2.7 (1H, m) 2.9 to 3.6 (2H, m) 3.7 to 4.4 (1H, m) 5.0 to 5.4 ( 1H, m) 7.2 to 7.45 (2H, m) IR (neat) 3400,2910,2250,745,695 cm -1 MS m / e 263 (M + ), 124 (100%) 6) Compound (B-1) Synthesis Hemiacetal (7-1) 986mg under argon stream
(3.75mM) in methylene chloride solution (20ml) triphenylphosphine ethoxycarbonylmethyl ylide 3.9g (11.25mM
M) and stir at room temperature for 15 hours. The solvent was distilled off from the reaction solution under reduced pressure, and the residue was subjected to silica gel column chromatography, and was extracted from the ether: hexane (3: 1 v / v) fraction to give 5
-Cyanomethyl-7-hydroxy-8-phenylthiooct-2-enoic acid ethyl ester (B-
1) was obtained as 1.03 g (82%) colorless oil. 1 HNMR (CDCl 3 ) δ: 1.29 (3H, t, J = 7.1Hz) 1.60 (2H, m) 2.0 to 2.7 (5H, m) 2.68 (1H, dd, J = 13.9,8.8Hz) 3.15 (1H, dd, J = 13.9,3.7Hz) 3.70 (1H, m) 4.90 (2H, q, J = 7.1Hz) 5.90 (1H, d, J = 15.6Hz) 6.80 (1H, dt, J = 15.6,7.1Hz) IR (neat) 3450,2910,2250,1910,1650,740,690 cm -1 MS m / e 333 (M + ), 124 (100%) 7) Synthesis of compound (B-3) To a solution of 87 mg (0.26 mM) of the compound (B-1) in 1 ml of ethanol was added 0.6 ml of Raney nickel 0.6 mM ethanol solution, and the mixture was heated under reflux at 90 ° C for 20 minutes, filtered through Celite, and the solvent was distilled off under reduced pressure. After removal, the residue was subjected to silica gel column chromatography, ether: hexane (7: 1v
/ V) fraction to obtain 37.2 mg (63%) of compound (B-3) as a colorless oily substance. 1 HNMR (CDCl 3 ) δ: 1.23 (3H, t, J = 6.3Hz) 1.26 (3H, t, J = 7.1Hz) 1.4 to 1.8 (7H, m) 1.95 (1H, m) 2.33 (2H, t, J = 6.6Hz) 2.48 (2H, d, J = 5.4Hz) 3.90 (1H, m) 4.14 (2H, g, J = 7.1Hz) IR (neat) 3400,2250,1725cm -1 MS m / e 228 ( M + 1), 164 (100%) Synthesis example Synthesis of compound (C-2) 250 mg (1.1 mM) of the above compound (B-3) under an argon stream.
It was dissolved in 30% aqueous potassium hydroxide solution (1 ml) and ethanol (8 ml) and heated under reflux for 12 hours. 30 ml ether and 20 water in the reaction mixture
ml, and extract and separate, add concentrated hydrochloric acid to the aqueous layer to make it acidic,
It was extracted with methylene chloride. The organic layers were combined and dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was dissolved with methylene chloride, and an ether solution of diazomethane was added to give methyl ester. The solvent was distilled off under reduced pressure,
The residue was subjected to silica gel column chromatography, and from an ether: hexane (1: 1 v / v) fraction (C-2).
192.1 mg (82%) was obtained as colorless crystals.
mp 72.5〜73℃1 HNMR(CDCl3) δ:1.38 (3H,d,J=6.3Hz) 1.1 〜2.9(11H,m) 3.68 (3H,s) 4.4 (1H,m) IR(CHCl3)2900,1720cm-1 MS m/e 215(M+1)、74(100%) 化合物(9)の合成 アルゴン気流下、化合物(C−2)178mg(0.83mM)のテ
トラヒドロフラン溶液2mlをカリウム−t−ブトキシド2
89.5mg(2.68mM)のテトラヒドロフランけんだく液8mlに
室温で加え、更に同温度で10分間撹拌した。反応液に水
20ml、エーテル30mlを加え、抽出分離した。水層を濃塩
酸で酸性とし、塩化メチレンで抽出し、有機層をあわせ
て無水硫酸マグネシウムで乾燥した後、減圧下で溶媒を
留去し、残渣をシリカゲルカラムクロマトグラフィーに
付し、エーテル:ヘキサン(1:5v/v)留分より化
合物(9)106mg(70%)を無色針状晶として得た。mp 72.5 to 73 ° C. 1 HNMR (CDCl 3 ) δ: 1.38 (3H, d, J = 6.3 Hz) 1.1 to 2.9 (11H, m) 3.68 (3H, s) 4.4 (1H, m) IR (CHCl 3 ) 2900 , 1720cm -1 MS m / e 215 (M + 1), 74 (100%) Synthesis of compound (9) Under an argon stream, 2 ml of a tetrahydrofuran solution of 178 mg (0.83 mM) of compound (C-2) was added to potassium-t-butoxide 2
89.5 mg (2.68 mM) of tetrahydrofuran suspension (8 ml) was added at room temperature, and the mixture was further stirred at the same temperature for 10 minutes. Water as the reaction liquid
20 ml and ether 30 ml were added, and the mixture was extracted and separated. The aqueous layer was acidified with concentrated hydrochloric acid, extracted with methylene chloride, the organic layers were combined and dried over anhydrous magnesium sulfate, the solvent was evaporated under reduced pressure, and the residue was subjected to silica gel column chromatography, ether: hexane. From the (1: 5 v / v) fraction, 106 mg (70%) of compound (9) was obtained as colorless needle crystals.
mp 121〜122℃ (lit.mp120〜121℃、F.H.Stodola,et al.Biochem.J.,9
3,92(1964)) ▲[α]27 D▼+18.1°(c=1.03,エタノール) (lit.[α]D+18.2°(c=1.15,エタノール,K.Mor
i,et al.Tetrahedron,41,5295(1985))mp 121-122 ° C (lit.mp 120-121 ° C, FHStodola, et al. Biochem. J. , 9
3, 92 (1964)) ▲ [α] 27 D ▼ + 18.1 ° (c = 1.03, ethanol) (lit. [α] D + 18.2 ° (c = 1.15, ethanol, K.Mor
i, et al. Tetrahedron , 41, 5295 (1985))
Claims (2)
アルキル基、アルケニル基又はベンジル基を、X′は水
素原子又はフェニルチオ基を、*は不斉炭素を表わ
す。) で表わされる光学活性カルボン酸エステル化合物。1. A general formula (B) (D-E is a CH = CH or CH 2 CH 2, R 3 is a lower alkyl group, an alkenyl group or a benzyl group, X 'is a hydrogen atom or a phenylthio group, * represents an asymmetric carbon.) Represented by Optically active carboxylic acid ester compound.
チル、プロピル、イソプロピル、ブチル、t−ブチル、
ペンチル基からなる低級アルキル基、アリル、2−メチ
ルアリル、2−ブテニル、3−ブテニル、2−ペンテニ
ル基からなるアルケニル基及びベンジル基の中から選ば
れることを特徴とする請求項1記載の光学活性カルボン
酸エステル化合物。2. In the general formula (B), R 3 is methyl, ethyl, propyl, isopropyl, butyl, t-butyl,
The lower alkyl group consisting of a pentyl group, allyl, 2-methylallyl, 2-butenyl, 3-butenyl, an alkenyl group consisting of a 2-pentenyl group and a benzyl group are selected, and the optically active compound according to claim 1. Carboxylic acid ester compound.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25022789A JPH066564B2 (en) | 1989-09-26 | 1989-09-26 | Optically active carboxylic acid ester compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25022789A JPH066564B2 (en) | 1989-09-26 | 1989-09-26 | Optically active carboxylic acid ester compound |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03112955A JPH03112955A (en) | 1991-05-14 |
JPH066564B2 true JPH066564B2 (en) | 1994-01-26 |
Family
ID=17204732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP25022789A Expired - Lifetime JPH066564B2 (en) | 1989-09-26 | 1989-09-26 | Optically active carboxylic acid ester compound |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH066564B2 (en) |
-
1989
- 1989-09-26 JP JP25022789A patent/JPH066564B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH03112955A (en) | 1991-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6809223B2 (en) | Process for stereoselective synthesis of prostacyclin derivatives | |
US10011582B2 (en) | Substituted delta-lactones and methods of preparing same | |
CA2873280C (en) | Improved process for the preparation of treprostinil and derivatives thereof | |
US20080312465A1 (en) | Intermediate compounds in the synthesis of dronabinol | |
CN109219601B (en) | Method for preparing optically active beraprost | |
US3532721A (en) | Cyclopentyl-alkanoic acids | |
HU184194B (en) | Process for producing new ethers containing chiralic carbon atoms | |
KR0144684B1 (en) | Mono esters of dicarboxylic acids and their prepartion and use | |
JP2540337B2 (en) | Process for producing dihydrocyclocitral and optically active stereoisomers of dihydrocyclocitral | |
JPH066564B2 (en) | Optically active carboxylic acid ester compound | |
JPH0643415B2 (en) | Process for producing optically active δ-lactone compound | |
JPH064613B2 (en) | Optically active δ-lactone compound | |
JPH0651690B2 (en) | Process for producing optically active δ-lactone compound | |
JPH0559115B2 (en) | ||
US4170596A (en) | Novel monoesters of cis-cyclopentenediol, process for preparation thereof, and process for preparation of lactones from the monoesters | |
JP2654835B2 (en) | Optically active 4-en-6-ol compounds, intermediates for their production and methods for their production | |
US4985571A (en) | 6-membered lactones useful as intermediates for antilipemic mevalonic acid lactones | |
JP2541197B2 (en) | Optically active cyclopentene derivative and its production method | |
HU202240B (en) | Process for producing optically active carbacycline intermediates | |
JP2517743B2 (en) | Production method of optically active alcohol | |
JP2743797B2 (en) | Preparation of optically active compounds | |
US4217284A (en) | Process for preparation of optically pure lactones from monoesters of cis-cyclopentenediol | |
JP2750874B2 (en) | (-)-3- (p-tolyl) glycidol | |
JP2718546B2 (en) | Stereoselective production of cyclopentenone derivatives | |
JP2654834B2 (en) | Optically active vinyl compound, intermediate for producing the same, and method for producing them |